Who should we target for diabetes prevention and diabetes risk reduction? (Q37980673)

26 August 2017

Who should we target for diabetes prevention and diabetes risk reduction? (English)

1 reference

26 August 2017

Thomas Yates

4

0 references

Peter Schwarz

8

object named as

Peter E H Schwarz

1 reference

26 August 2017

Susann Blüher

1

1 reference

26 August 2017

Jana Markert

2

1 reference

26 August 2017

Sabine Herget

3

1 reference

26 August 2017

Melanie Davis

5

1 reference

26 August 2017

Gabriele Müller

6

1 reference

26 August 2017

Thomas Waldow

7

1 reference

26 August 2017

1 April 2012

1 reference

26 August 2017

Current diabetes report

1 reference

26 August 2017

12

1 reference

26 August 2017

2

1 reference

26 August 2017

147-156

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0255-x

26 August 2017

0 references

cites work

Prevention of type 2 diabetes: the strategic approach for implementation

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Prevention of diabetes mellitus in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study: results from a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A risk score for predicting incident diabetes in the Thai population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

The Finnish Diabetes Risk Score is associated with insulin resistance and progression towards type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A Danish diabetes risk score for targeted screening: the Inter99 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

The diabetes risk score: a practical tool to predict type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Tools for predicting the risk of type 2 diabetes in daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A European evidence-based guideline for the prevention of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Pre-diabetes essential action: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Can a screening programme for diabetes be applied to another population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians - the Chennai Urban Rural Epidemiology Study (CURES-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

The performance of a risk score in predicting undiagnosed hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Plasma glucose concentration and prediction of future risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabete

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A1C level and future risk of diabetes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Exercise as a therapeutic intervention for the prevention and treatment of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Epidemiological evidence for the role of physical activity in reducing risk of type 2 diabetes and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Low physical activity and obesity: causes of chronic disease or simply predictors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

International prevalence of physical activity in youth and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Physical activity in the United States measured by accelerometer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

International physical activity questionnaire: 12-country reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Population-level effects of the national diabetes prevention programme (FIN-D2D) on the body weight, the waist circumference, and the prevalence of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Common variants near MC4R are associated with fat mass, weight and risk of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Newly identified loci that influence lipid concentrations and risk of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Variants in MTNR1B influence fasting glucose levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Meta-analysis of 23 type 2 diabetes linkage studies from the International Type 2 Diabetes Linkage Analysis Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Common variants at 30 loci contribute to polygenic dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Obesity, gestational diabetes and pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Maternal gestational diabetes, birth weight, and adolescent obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Higher maternal gestational glucose concentration is associated with lower offspring insulin sensitivity and altered beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Prenatal origin of obesity and their complications: Gestational diabetes, maternal overweight and the paradoxical effects of fetal growth restriction and macrosomia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Nutritional programming affects hypothalamic organization and early response to leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Age-specific stabilization in obesity prevalence in German children: a cross-sectional study from 1999 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Type 2 diabetes in younger adults: the emerging UK epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Childhood body-mass index and the risk of coronary heart disease in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Lifestyle modification and metformin as long-term treatment options for obese adolescents: study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schwarz et al

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Does Waist Circumference Predict Diabetes and Cardiovascular Disease Beyond Commonly Evaluated Cardiometabolic Risk Factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

From evidence to practice—the IMAGE project—new standards in the prevention of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0255-X

Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

21 January 2018

1 reference

12 December 2020

High Visceral Fat Mass and High Liver Fat Are Associated with Resistance to Lifestyle Intervention*

1 reference

12 December 2020

The Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: are improvements in glucose regulation sustained at 2 years?

1 reference

12 December 2020

Abnormal 1 hour glucose challenge test followed by a normal 3 hour glucose tolerance test: does it identify adverse pregnancy outcome?

1 reference

12 December 2020

Trend and prevalence estimates based on the 2008 Physical Activity Guidelines for Americans

1 reference

12 December 2020

The metabolic syndrome in children and adolescents

1 reference

12 December 2020

Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels

1 reference

12 December 2020

Genome-wide association study identifies eight loci associated with blood pressure

1 reference

12 December 2020

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

1 reference

12 December 2020

An Accurate Risk Score Based on Anthropometric, Dietary, and Lifestyle Factors to Predict the Development of Type 2 Diabetes: Response to Schulze et al

1 reference

12 December 2020

Type 2 diabetes in children and adolescents. American Diabetes Association

1 reference

12 December 2020

10.1007/S11892-012-0255-X

Identifiers

DOI

1 reference

26 August 2017

1 reference